Use of a Fentanyl Patch Throughout Pregnancy

Journal of Obstetrics and Gynaecology Canada

Volumn 31, Issue 1, 2009, Pages 20-

  Einarson, Adrienne ^a   Taguchi, Nobuko ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; NARCOTIC ANALGESIC AGENT;

ANALGESIA; CHRONIC DRUG ADMINISTRATION; CHRONIC PAIN; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG SAFETY; HUMAN; INAPPROPRIATE PRESCRIBING; LETTER; OUTCOME ASSESSMENT; PATCH; PREGNANCY; PRENATAL DRUG EXPOSURE; WITHDRAWAL SYNDROME; FEMALE; FETUS; INTRACTABLE PAIN; INTRADERMAL DRUG ADMINISTRATION; METABOLISM;

ADMINISTRATION, CUTANEOUS; ANALGESICS, OPIOID; FEMALE; FENTANYL; FETUS; HUMANS; PAIN, INTRACTABLE; PREGNANCY;

EID: 63149177226     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34048-8     Document Type: Letter

References (5)

1. Product Monograph Janssen-Ortho Inc. Markham, ON. Revised May 2008.
2. Collado F., Torres L.M. Association of transdermal fentanyl and oral transmucosal fentanyl citrate in the treatment of opioid naive patients with severe chronic non cancer pain. J Opioid Manag 2008 Mar-Apr, 4(2):111-115.
3. US Food and Drug Administration. 2005 safety alerts for drugs, biologics, medical devices, and dietary supplements. Available at: http://www.fda.gov/medWatch/SAFETY/2005/safety05.htm. Accessed October 29, 2008.
4. The Institute for Safe Medication Practices Canada (ISMP Canada). Fentanyl patch linked to another death in Canada. ISMP Canada Safety Bulletin; November 13, 2007. Available at: http://www.ismp-canada.org/download/ISMPCSB2007-05Fentanyl.pdf. Accessed October 29, 2008.
5. Regan J, Chambers F, Gorman W, et al. Neonatal abstinence syndrome due to prolonged administration of fentanyl in pregnancy. BJOG 2000;107:570-2.